HOME >> BIOLOGY >> NEWS
SWI/SNF and erythropoiesis

A research team headed by Dr. Scott Bultman (University of North Carolina) has identified an essential role for the mammalian SWI/SNF chromatin remodeling complex in red blood cell formation. The authors generated a partial loss-of-function mutations in the ATPase domain of the SWI/SNF catalytic subunit, Brg1, effectively uncoupling its ATPase and chromatin remodeling activities.

Brg1-mutant mice die at mid-gestation due to defective erythropoiesis. Commenting on the relevance to human disease, the authors pointed out that "although much is known about the biochemistry of SWI/SNF chromatin-remodeling complexes, not as much is known about their role in development and physiology.

This Brg1 mutation is significant because it reveals a role for these complexes in beta-globin regulation and erythropoiesis and may provide insight into common ailments such as beta thalassemia and anemia."


'"/>

Contact: Heather Cosel
coselpie@cshl.edu
Cold Spring Harbor Laboratory
13-Nov-2005


Page: 1

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Identified main genetic variants involved in response to HIV
3. Which genome variants matter?
4. Gene variants reveal susceptibility to cardiovascular disease
5. Three human gene variants appear to influence tb susceptibility
6. Is brain size linked to two common gene variants?
7. Genetic variants and breast cancer risk, genetics and suicidal behavior, and more
8. Einstein researchers identify genetic variants that lend clues to living longer
9. Gene variants linked with increased risk of death among heart patients treated with beta-blockers
10. Gene variants predict bleeding after heart surgery
11. Mitochondrial DNA variants linked to renal, prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: